Affiliation:
1. Department of Neurology, Center for Cognitive Neurology
2. Medicine
3. Centro de Investigación en Hematología y Trastornos Afines (CIHATA)
4. Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica
5. Psychiatry
6. Population of Health
7. Neuroscience Institute, NYU Grossman School of Medicine, New York, NY
Abstract
Background:
We examined drivers of self and study partner reports of memory loss in mild cognitive impairment (MCI) from Alzheimer (AD-MCI) and vascular disease (Va-MCI).
Methods:
We performed retrospective cross-sectional analyses of participants with AD-MCI (n=2874) and Va-MCI (n=376) from the National Alzheimer’s Coordinating Center data set. Statistical analysis utilized 2-sided t test or the Fisher exact test.
Results:
Compared with AD-MCI, Va-MCI subjects (24.5% vs. 19.7%, P=0.031) and study partners (31.4% vs. 21.6%, P<0.0001) were more likely to deny memory loss. Black/African Americans were disproportionately represented in the group denying memory loss in AD-MCI (20.0% vs. 13.2%, P<0.0001) and Va-MCI (33.7% vs. 18.0%, P=0.0022). Study partners of participants with these features also disproportionately denied memory loss: female (AD-MCI: 60.1% vs. 51.7%, P=0.0002; Va-MCI: 70.3% vs. 52.3%, P=0.0011), Black/African American (AD-MCI: 23.5% vs. 11.98%, P<0.0001; Va-MCI: 48.8% vs. 26.5%, P=0.0002), and <16 years of education (AD-MCI only: 33.9% vs. 16.3%, P=0.0262). In AD-MCI and Va-MCI, participants with anxiety were disproportionately represented in the group endorsing memory loss (AD: 28.2% vs. 17.4%, P<0.0001; Va: 31.5% vs. 16.1%, P=0.0071), with analogous results with depression.
Conclusion:
The findings would suggest extra vigilance in interview-based MCI detection of persons at-risk for self-based or informant-based misreport.
Publisher
Ovid Technologies (Wolters Kluwer Health)